# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Anamorelin | 5621 | PPB | 93.67 | % | ALA3301367 | % | |||||
2. | Anamorelin | 5621 | PPB | 84 | % | ALA3301366 | % | |||||
3. | Anamorelin | 5621 | PPB | 78.01 | % | ALA3301369 | % | |||||
4. | Anamorelin | 5621 | CLint | 8.91 | microL/min/1E6 cells | ALA3301372 | uL.min-1.(10^6cells)-1 | |||||
5. | Anamorelin | 5621 | LogD7.4 | 2.1 | ALA3301363 | |||||||
6. | Anamorelin | 5621 | Inhibition | = | 0.22 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | Anamorelin | 5621 | inhibition | = | -6.92 | % | ALA4808150 | % | Homo sapiens | |||
8. | Anamorelin | 5621 | inhibition | = | -33.49 | % | ALA4808149 | % | Homo sapiens | |||
9. | Anamorelin | 5621 | inhibition | = | 0.26 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
10. | Anamorelin | 5621 | inhibition | = | 0.26 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
11. | Anamorelin | 5621 | Inhibition | = | 2.117 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 |